Kausik Ray MD FMedSci/LinkedIn
Nov 1, 2025, 05:15
Kausik Ray Celebrates MENA Launch of ACLY Inhibitor
Kausik Ray, Professor of Public Health at Imperial College London, Past President of European Atherosclerosis Society, posted on LinkedIn:
”One of the exciting things I have had the honoring of doing over the years are launch meetings. Bringing new therapies from the first PCSK9 MAbs, then to the first siRNA inclisiran and now the first ACLY inhibitor Bempedoic acid in the MENA region.
Good discussions about the CVD, lipids, guidelines and where new therapies sit in this this region at high risk for CVD.
The last 15 years of time spent on education, awareness, simplicity continue to help bring improvements in patient care.”
Stay informed with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis